Trust in healthcare providers, information sources, and concerns for new maternal vaccines among pregnant and lactating women in Kenya
Bibliographic Data
| ID | 19594072 |
|---|---|
| Authors | Jessica L Schue (0000-0002-5188-5692, Johns Hopkins University, corresponding author), Berhaun Fesshaye (0000-0003-2868-4187, Johns Hopkins University, corresponding author), Emily Miller (0000-0003-1823-983X, Johns Hopkins University, corresponding author), Prachi Singh (0000-0001-9890-6051, Johns Hopkins University, corresponding author), Molly Sauer (0000-0002-5837-6997, Johns Hopkins University, corresponding author), Rosemary Njogu (corresponding author), Rose Jalang’o (0000-0003-3457-2587, Ministry of Health, corresponding author), Joyce U Nyiro (0000-0001-7215-6539, Kenya Medical Research Institute, corresponding author), Joyce Nyiro, Ruth A Karron (0000-0002-4448-4946, Johns Hopkins University, corresponding author), Rupali J Limaye (0000-0002-3883-9720, Johns Hopkins University, corresponding author) |
| Editors | Claire E von Mollendorf |
| Year | 2025 |
| Volume | 5 |
| Issue | 11 |
| Pages | e0004499 |
| Publication date | 2025-11-12 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | PLOS Global Public Health (JOURNAL) |
| Journal identifiers | ISSN: 2767-3375 • E-ISSN: 2767-3375 |
| Publisher | Public Library of Science (PLoS) (PUBLISHER) |
| DOI | 10.1371/journal.pgph.0004499 |
| PMID | 41223190 |
| OpenAlex | W4416149216 |
| Language | EN |
| References cited | 41 |
New maternal vaccines have the potential to reduce morbidity and mortality for infants from common illnesses that pose the greatest risk in the earliest phase of their life. Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections among infants under six months of age. With the recent approval of a maternal vaccine for RSV, this study aimed to understand decision-making factors among pregnant and lactating women for receiving a newly licensed vaccine during pregnancy. Pregnant and lactating women from two counties in Kenya, Nakuru and Mombasa, were recruited to complete a cross-sectional survey in July-September 2022. The survey explored topics of trust in various types of sources for information about new maternal vaccines, the importance of a healthcare provider’s recommendation of a new maternal vaccine, and concerns about new maternal vaccines. We surveyed 400 pregnant and lactating women. In both counties, information about the new vaccine was most trusted when coming from healthcare providers, and least trusted when coming from social media. Women’s intention to receive a new maternal vaccine was heavily influenced by a positive recommendation from a healthcare provider. The greatest concerns about a new vaccine were side effects and the vaccine’s ingredients. The information and recommendation from a healthcare provider are important influences on decision-making for new maternal vaccines. As a new maternal immunization for RSV becomes more available, healthcare providers should be engaged early to reduce vaccine hesitancy amongst providers and equip providers with appropriate information tailored to pregnant women about the RSV maternal vaccine
Health care · Immunization · Maternal health · Pandemic · Pregnancy · Respiratory infection · Vaccination · COVID-19 Impact on Reproduction · Respiratory viral infections research · Vaccine Coverage and Hesitancy
Development of a survey to identify vaccine-hesitant parents
Measuring vaccine hesitancy
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019
Beyond confidence
Social Learning Theory and the Health Belief Model
A qualitative inquiry in understanding trusted media sources to reduce vaccine hesitancy among Kenyans
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya
| Citation velocity | historical |
|---|---|
| Highly cited | No |